Correlation Between Crinetics Pharmaceuticals and Innovent Biologics
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Innovent Biologics, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Innovent Biologics.
Diversification Opportunities for Crinetics Pharmaceuticals and Innovent Biologics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crinetics and Innovent is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Innovent Biologics go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Innovent Biologics
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.48 times more return on investment than Innovent Biologics. However, Crinetics Pharmaceuticals is 2.1 times less risky than Innovent Biologics. It trades about 0.0 of its potential returns per unit of risk. Innovent Biologics is currently generating about -0.02 per unit of risk. If you would invest 5,715 in Crinetics Pharmaceuticals on August 29, 2024 and sell it today you would lose (38.00) from holding Crinetics Pharmaceuticals or give up 0.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Crinetics Pharmaceuticals vs. Innovent Biologics
Performance |
Timeline |
Crinetics Pharmaceuticals |
Innovent Biologics |
Crinetics Pharmaceuticals and Innovent Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Crinetics Pharmaceuticals and Innovent Biologics
The main advantage of trading using opposite Crinetics Pharmaceuticals and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Scpharmaceuticals | Crinetics Pharmaceuticals vs. Milestone Pharmaceuticals | Crinetics Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |